InspireMD, Inc. (NYSE:NSPR) Shares Sold by Nantahala Capital Management LLC

Nantahala Capital Management LLC lessened its stake in InspireMD, Inc. (NYSE:NSPR - Free Report) by 24.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,674,565 shares of the company's stock after selling 535,028 shares during the period. Nantahala Capital Management LLC owned 6.42% of InspireMD worth $4,404,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Renaissance Technologies LLC acquired a new position in InspireMD during the 4th quarter worth approximately $27,000. Legato Capital Management LLC purchased a new stake in InspireMD in the 4th quarter valued at approximately $47,000. Northern Trust Corp lifted its stake in InspireMD by 103.7% in the 4th quarter. Northern Trust Corp now owns 48,022 shares of the company's stock valued at $126,000 after buying an additional 24,452 shares in the last quarter. Essex Investment Management Co. LLC purchased a new stake in InspireMD in the 4th quarter valued at approximately $191,000. Finally, Affiance Financial LLC lifted its stake in shares of InspireMD by 2.9% during the 4th quarter. Affiance Financial LLC now owns 189,122 shares of the company's stock worth $497,000 after purchasing an additional 5,376 shares during the period. Institutional investors and hedge funds own 44.78% of the company's stock.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on InspireMD in a research report on Sunday. They issued a "sell" rating on the stock.

InspireMD Stock Performance

Shares of NYSE NSPR traded up $0.06 during midday trading on Thursday, reaching $2.60. 59,892 shares of the company's stock were exchanged, compared to its average volume of 35,303. InspireMD, Inc. has a 52-week low of $1.95 and a 52-week high of $3.80. The stock has a market capitalization of $79.65 million, a PE ratio of -3.47 and a beta of 0.74. The business's fifty day moving average price is $2.75 and its two-hundred day moving average price is $2.74.

InspireMD Profile

InspireMD, Inc, a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions.